Skip to content
naulon
Not checkedNot checked for notices yet.

Author Correction: Positron emission tomography imaging with 89Zr-labeled anti-CD8 cys-diabody reveals CD8+ cell infiltration during oncolytic virus therapy in a glioma murine model

Benjamin B. Kasten, Hailey A. Houson, Jennifer M. Coleman and 10 more

Scientific Reports · 2021

doi:10.1038/s41598-021-00042-x (opens in a new tab)

We email you when a new notice or a question about this paper appears.

Abstract

“Yolanda Hartman, Sheila Bright, Catherine Langford, Sharon Samuel, Erika McMillian, Brian Wright, Lauren Radford, Charlotte Jeffers, Jennifer Bartels, Tolulope Aweda, Jonathan McConathy, Jinda Fan, Norio Yasui, Dattatray Devalankar, Himani Modi, Morgan Richardson, and staff of the University of Alabama Cyclotron Facility are gratefully acknowledged for their contributions and informative discussions. Funding was provided by the National Institutes of Health/National Institute of Neurological Disorders and Stroke T32 UAB Training Program in Brain Tumor Biology (T32 NS048039), the UAB Brain Tumor Core Facility (USPHS NCI P20CA151129), the National Center for Advancing Translational Research of the National Institutes of Health (UL1TR001417), the American Cancer Society (RSG-18-006-01-CCE), National Cancer Institute (R01CA24058) and the Comprehensive Cancer Center at UAB (NIH P30CA013148). JWL is supported by funding from the Department of Defense (W81XWH-18-1-0315) and National Institutes of Health (R01AI148711). JMW is supported by the Department of Defense (RCRP CA170769). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.”

Abstract licence: CC BY-NC-ND

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.